Direct answer. Ventricular fibrillation, or VF, prevents the ventricles from pumping effectively and causes cardiac arrest. An unresponsive person who is not breathing normally needs the local emergency service immediately, CPR following dispatcher instructions and an AED if available. Bystanders should act on the arrest signs rather than wait to identify the exact rhythm.
- VF is a ventricular electrical rhythm that stops effective circulation.
- Ventricular fibrillation and atrial fibrillation are very different clinical situations.
- The bystander response is based on unresponsiveness and abnormal breathing.
- An AED analyzes the rhythm and gives instructions, including whether a shock is advised.
- Survival requires hospital care and investigation of the cause, not only a restored pulse.
Evidence summary
| Question | Source role | Conclusion and confidence |
|---|---|---|
| What happens? | NHLBI rhythm types | The ventricles quiver instead of pumping effectively; this is an arrest emergency. |
| What should a bystander recognize? | NHS fainting | Unresponsiveness and not breathing normally; do not delay to diagnose VF. |
| What follows emergency treatment? | NHLBI cardiac arrest treatment | Hospital support, cause investigation and a plan to address further risk. |
Confidence is high in the condition distinctions and need for appropriate assessment. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.
What it is
Ventricular fibrillation is disorganized electrical activity in the heart’s lower chambers. The ventricles cannot produce effective pumping, so circulation to the brain and other organs stops. It is not a routine palpitation episode and cannot be treated with a home supplement or a relaxation exercise. NHLBI rhythm types.
Atrial fibrillation affects the upper chambers and has different immediate and longer-term concerns. The shared word “fibrillation” should not obscure this difference. A person reading a monitor report or discharge summary should confirm which rhythm is being described. NHLBI rhythm types.
How it works
Normal coordinated ventricular activity is replaced by ineffective quivering. The lack of effective blood flow rapidly becomes life-threatening. VT can be associated with a deterioration to VF, while several underlying cardiac or electrical problems can contribute to an arrest. Investigation is needed after survival to understand the cause. NHLBI cardiac arrest.
An arrest does not always have VF as its recorded rhythm. A bystander cannot reliably determine the rhythm from the person’s appearance. The immediate need is to recognize the arrest signs and start the emergency response; an AED or medical team assesses the electrical pattern. NHLBI cardiac arrest treatment.
The evidence-based treatments
Call the local emergency service for an unresponsive person who is not breathing normally. Start CPR as instructed by the dispatcher and use an available AED according to its prompts. The device analyzes the rhythm and advises a shock when appropriate. Do not wait for a home device, symptom history or pulse-counting exercise to identify VF. NHS fainting; NHLBI cardiac arrest treatment.
Emergency responders continue resuscitation and deliver rhythm-specific care. If circulation returns, hospital treatment addresses cardiac and other organ injury, including the brain, while the cause is investigated. Restoring circulation is a crucial event but does not settle the extent of injury or long-term outcome. NHLBI cardiac arrest treatment.
Further assessment can involve ECG, blood tests, heart imaging and selected electrical or genetic evaluation. The question is why the dangerous rhythm happened and what ongoing risk remains. A coronary event, an inherited electrical condition and another mechanism do not lead to one universal follow-up package. NHLBI arrhythmia diagnosis.
Selected survivors may be offered an implantable defibrillator or another cause-specific treatment. The team should explain why the device or medicine is appropriate, what it can and cannot do, and the monitoring required. This article does not rank device brands or claim that all post-arrest patients have the same indication. NHLBI arrhythmia treatment.
Supplement and lifestyle evidence
Lifestyle planning belongs to recovery after stabilization. It must reflect the cause, cardiac function, neurological recovery and any device or medicine plan. Community CPR/AED training can help others respond to an arrest, but it does not replace specialist prevention for someone at risk. NHLBI cardiac arrest treatment.
No supplement is established here as a treatment for ventricular fibrillation. “Heart support,” improved vessel relaxation, a changed blood marker and fewer clinical events are different claims. The cited source set does not provide a fully financially screened trial basis for replacing diagnosis or prescribed care. Correcting a clinician-confirmed deficiency is a separate indication; a retail blend is not a diagnostic test or an emergency treatment.
What works and what does not
Useful care separates recognition and resuscitation from cause investigation and secondary prevention. A restored rhythm, discharge survival and longer-term functional recovery are different outcomes that should not be presented as one success measure.
Ask which outcome is being pursued: symptoms, physiological findings, recurrence, hospital admission or survival. A plan should also say how adverse effects and deterioration will be recognized. Personal stories and before-and-after readings cannot separate treatment effects from the natural course, other medicines or selection of patients. Manufacturer or materially conflicted outcome claims do not determine this article’s independent verdict.
Risks and side effects
Active VF has no safe watch-and-wait phase outside resuscitation. Collapse with unresponsiveness and abnormal or absent breathing demands emergency action. Gasping can be abnormal breathing and should not be mistaken for reassuring recovery. NHLBI cardiac arrest; NHS fainting.
Resuscitation and intensive hospital treatment occur in a life-threatening situation. Subsequent device or drug decisions have specific risks, including procedural complications and unwanted rhythm effects. Those trade-offs should be discussed when the person is stable enough, rather than interpreted as a reason to delay an emergency response. NHLBI arrhythmia treatment.
Important interactions
After survival, reconcile every medicine and product with the established cause and rhythm-risk plan. An implantable device does not make every rhythm-affecting medicine safe. Report significant new symptoms or shocks using the instructions supplied by the clinical team. NHLBI arrhythmia treatment.
Bring prescription medicines, non-prescription products, recreational drugs and supplements to the same medication review. Product names alone may hide several active ingredients. The prescriber or pharmacist should check the exact combination and kidney function, rather than treating “natural” as a safety category. Never add a second person’s rescue medicine or stop an important prescribed medicine because an internet list mentions a possible interaction.
Who needs assessment
Survivors require assessment of the cause and ongoing risk. A history of unexplained sudden death in the family may affect whether inherited-rhythm evaluation is appropriate. Family testing should be clinician-led and based on the actual findings. NHLBI arrhythmia diagnosis.
A person with recurring symptoms needs a clear review route even when a brief earlier ECG was reassuring. Record the timing and circumstances for the clinician, rather than provoking another episode to prove what it is. NHLBI arrhythmia diagnosis.
Clinician-led use and follow-up
Ask which cause was found, what remains uncertain, whether family assessment is relevant and how recovery will be supported. If a device is implanted, obtain clear instructions about follow-up, alerts or shocks and communication with other healthcare providers. NHLBI arrhythmia treatment.
This guide gives no personal drug, device or supplement dose. The appropriate plan depends on the established diagnosis, current stability, other illnesses and local services. Ask for a written explanation of the treatment purpose, warning signs, review schedule and contact route for side effects. Clinical monitoring and informed consent should accompany any change; study exposures are not prescriptions.
Animal and in-vitro evidence
Cell and animal experiments on vessel function or cardiac stress can suggest mechanisms. They do not establish safe human dosing, symptom improvement or fewer serious events. A laboratory preparation and a retail product may differ in composition, absorption and exposure. No animal or in-vitro result contributes to the independent clinical verdict in this guide.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 7 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
The financial stakes include ECG monitoring, electrophysiology services, antiarrhythmic medicines, implanted devices and ablation. Diagnostic yield, symptom relief and prevention of a serious event are distinct claims. No commercially supported efficacy result establishes the independent verdict in this guide.
The condition has no corporate owner. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.
| Source | Funding / backers | Country / jurisdiction | Independence | Credibility / incentives / gaps |
|---|---|---|---|---|
| NHLBI rhythm types | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: VF mechanism and chamber distinction. |
| NHLBI cardiac arrest | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Cardiac-arrest recognition. |
| NHLBI cardiac arrest treatment | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Emergency and hospital treatment context. |
| NHS fainting | DHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved. | United Kingdom; England national public-information service. Other jurisdictions have different services. | Tier 1 public education provisional; not a clearance of original studies. | B provisional. Public-service remit and editorial checks support accuracy; simplification, service priorities and incomplete trial-finance tracing limit inference. Role: UK collapse and urgent-warning guidance. |
| NHLBI arrhythmia diagnosis | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Cause and electrical/structural investigation context. |
| NHLBI arrhythmia treatment | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Selected long-term device and rhythm-care context. |
| NHLBI arrhythmias | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Additional original linked in condition-specific education or follow-up. |
| NHLBI budget | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHLBI Gift Fund | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHS national website funding policy | DHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved. | United Kingdom; England national public-information service. Other jurisdictions have different services. | Tier 3 editorial and financial self-disclosure. | B provisional. Explicit funding policy; actual individual declarations and implementation not audited. Financial provenance only. |
Frequently asked questions
Is VF the same as AF?
No. Ventricular and atrial fibrillation have very different consequences. NHLBI rhythm types.
Should I diagnose the rhythm before calling?
No. Act on unresponsiveness and abnormal breathing. NHS fainting.
Does an AED shock every collapsed person?
It assesses the rhythm and gives prompts, including whether a shock is advised. NHLBI cardiac arrest treatment.
Is care complete when the pulse returns?
No. Hospital treatment and investigation remain essential. NHLBI cardiac arrest treatment.
Sources and funding notes
- NHLBI rhythm types — VF mechanism and chamber distinction.
- NHLBI cardiac arrest — Cardiac-arrest recognition.
- NHLBI cardiac arrest treatment — Emergency and hospital treatment context.
- NHS fainting — UK collapse and urgent-warning guidance.
- NHLBI arrhythmia diagnosis — Cause and electrical/structural investigation context.
- NHLBI arrhythmia treatment — Selected long-term device and rhythm-care context.
- NHLBI arrhythmias — Additional original linked in condition-specific education or follow-up.
- NHLBI budget — Financial provenance only.
- NHLBI Gift Fund — Financial provenance only.
- NHS national website funding policy — Financial provenance only.
Original clinical pages and their relevant financial disclosures were opened. Where cited, the 2026 definition was read through the web tool; its author supplement was inaccessible and remains an explicit gap. Where cited, the 2018 SCAD papers were read in original full versions, including funding and disclosure tables. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.
Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.